Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-26T16:35:46.794Z Has data issue: false hasContentIssue false

5 - Covid-19

from Section 2 - Infectious Disease Emergencies

Published online by Cambridge University Press:  02 November 2023

By
John Rozehnal  and
Melissa Villars
Edited by
Kaushal Shah  and
Jarone Lee
Edited in association with
Clark G. Owyang  and
Benjamin Christian Renne
Kaushal Shah
Affiliation:
Weill Cornell Medical Center, New York
Jarone Lee
Affiliation:
Massachusetts General Hospital, Boston
Clark G. Owyang
Affiliation:
Weill Cornell Medical Center, New York
Benjamin Christian Renne
Affiliation:
Massachusetts General Hospital, Boston
Get access

Summary

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the pandemic declared in March 2020. While many of the manifestations (i.e., acute respiratory distress syndrome [ARDS]) are similar to other severe respiratory viruses, there is an increasing number of specific therapeutics found to be effective in combating coronavirus disease 2019 (COVID-19). As data emerge on the optimal treatment of COVID-19, the recommendations in this chapter are based on the current consensus from large global health and infectious disease authorities but are subject to evolution of the evidence.

Keywords

pandemicvirushypoxiaacute respiratory distress syndromeARDSsteroidsCOVID-19
Type
Chapter
Information
Practical Emergency Resuscitation and Critical Care , pp. 49 - 57
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Avari, H, Hiebert, RJ, Ryzynski, AA, et al. Quantitative assessment of viral dispersion associated with respiratory support devices in a simulated critical care environment. Am J Respir Crit Care Med 2021;203(9):1112–1118. https://doi.org/10.1164/rccm.202008-3070OCCrossRefGoogle Scholar
Brower, RG, Matthay, MA, Morris, A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New Engl J Med 2000;342(18):1301–1308.Google ScholarPubMed
Gottlieb, RL, Nirula, A, Chen, P, et al. Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial. JAMA 2021;325(7):632–644. https://doi.org/10.1001/jama.2021.0202CrossRefGoogle ScholarPubMed
Janiaud, P, Axfors, C, Schmitt, AM, et al. Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19: A systematic review and meta-analysis. JAMA 2021;325(12):1185–1195. https://doi.org/10.1001/jama.2021.2747CrossRefGoogle ScholarPubMed
Korley, FK, Durkalski-Mauldin, V, Yeatts, SD, et al. Early convalescent plasma for high-risk outpatients with COVID-19. N Engl J Med 2021;385(21):1951–1960. https://doi.org/10.1056/NEJMoa2103784CrossRefGoogle ScholarPubMed
Libster, R, Pérez, MG, Wappner, D, et al. Early high-titer plasma therapy to prevent severe COVID-19 in older adults. N Engl J Med 2021;384(7):610–618. https://doi.org/10.1056/NEJMoa2033700CrossRefGoogle ScholarPubMed
Saniasiaya, J, Islam, MA, Abdullah, B. Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): A meta-analysis of 27,492 patients. Laryngoscope 2021;131(4):865–878. https://doi.org/10.1002/lary.29286CrossRefGoogle Scholar
Silva, FAFD, Brito, BB, Santos, MLC, et al. COVID-19 gastrointestinal manifestations: A systematic review. Rev Soc Bras Med Trop 2020;53:e20200714. https://doi.org/10.1590/0037-8682-0714-2020CrossRefGoogle ScholarPubMed
Solomon, IH, Normandin, E, Bhattacharyya, S, et al. Neuropathological features of Covid-19. N Engl J Med 2020;383(10):989–992. https://doi.org/10.1056/NEJMc2019373CrossRefGoogle ScholarPubMed
Wong, HYF, Lam, HYS, Fong, AHT, et al. Frequency and distribution of chest radiographic findings in patients positive for COVID-19. Radiology 2020;296(2):E72–E78.CrossRefGoogle ScholarPubMed
Zhao, W, Zhong, Z, Xie, X, et al. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: A multicenter study. Am J Roentgenol 2020;214(5):1072–1077.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×